The Global Blood Filtering Device Market Size valued for USD 395.7 Million in 2021 and is anticipated to reach USD 597.5 Million by 2030 with a CAGR of 4.7% from 2022 to 2030.

The Food and Drug Administration (FDA) has designated Immunicon's Immunopheresis therapy as a "Breakthrough Device," a blood-filtering device that selectively eliminates immune inhibitors from the bloodstream in order to potentially strengthen the body's defence against tumours. The FDA quickly approved an emergency authorization for CytoSorbents' system after doing the same for Terumo BCT's blood filtering device for COVID-19. Both are intended to remove the immune system proteins that underlie the disease's lethal cytokine-storm reactions.

The D2000 Adsorption Cartridge from Marker Therapeutics, along with the Spectra Optia Apheresis System from Terumo BCT, is now approved for use in adult COVID-19 patients who are experiencing respiratory failure.

It is hoped that by reducing the levels of cytokines and other proteins in blood that encourage inflammation, the device will help to lessen some of the terrible effects of the infection. These include death by shock, lung failure, and other organ failure.

Blood Filtering Device Market Dynamics

The market value is being driven by the rising incidence of blood-transfusion-dependent illnesses like cancer, anaemia, sickle cell disease, and bleeding disorders like haemophilia. The market demand for blood filtering devices is accelerating due to the rising number of patients with chronic kidney diseases (CKD). CKD is frequently brought on by high blood pressure and does not get better with time. It prevents the kidneys from functioning normally, necessitating the use of an external machine for dialysis, which helps to filter and purify the blood.

By reducing a variety of pathogens, cytokines, and other inflammatory mediators-small active proteins in the bloodstream that regulate a cell's immune response-by filtering the blood and giving the filtered blood back to the patient, blood purification devices may be efficient in eliminating some patients with confirmed COVID-19. The removed proteins are typically raised during infections and may be linked to a "cytokine storm" that may happen in some COVID-19 patients, which may result in severe inflammation, rapidly progressing shock, respiratory failure, organ failure, and death.

Blood Filtering Device Market Insights

Type, applications, end-user, are the three segments of the market for blood filtering device. Based on the type; the market is segmented into three categories: hemodialysis membranes, leukocyte removal filter, and plasma separation membranes. The applications segment covers Blood Processing and Blood Transfusion (red cell transfusion, platelet transfusion, and whole blood transfusion). Furthermore, the end-user segment is categorized into medical centre, hospitals, ambulatory surgical centre, and others.

Global Blood Filtering Device Market Geographical Competition

Due to the rising prevalence of chronic diseases and the growing geriatric population, North America currently holds the largest revenue share in the market. The value of the regional market is primarily driven by the area's major economies, including the US and Canada. In the US, diabetes and high blood pressure are the main causes of CKD, which affects about 13% of adults. Furthermore, from 2022 to 2030, Asia Pacific is anticipated to grow at the fastest rate with a significant CAGR (%).

Global Blood Filtering Device Industry Segment Analysis

Blood Filtering Device Market By Type

·         Hemodialysis Membranes

·         Leukocyte Removal Filter

·         Plasma Separation Membranes

Blood Filtering Device Market By Applications

·         Blood Processing

·         Blood Transfusion

o   Red Cell Transfusion

o   Platelet Transfusion

o   Whole Blood Transfusion

Blood Filtering Device Market By End-User

·         Hospitals

·         Medical Centre

·         Ambulatory Surgical Centre

·         Others

Blood Filtering Device Market Leading Companies

The players profiled in the report are Asahi Kasei Medical, Braile Biomédica, BAINE, Chengdu Shuanglu, Merck & Co., Inc., GVS, Haemonetics, Kaneka, Infomed, Macopharma, KAWASUMI, Medtronic, MITRA, Nanjing Shuangwei, Nanjing Celgene, Shandong Zhongbaokang, and Terumobct.

Blood Filtering Device Market Regions